Chemoinformaics analysis of 4-HYDROXY-4-METHYL-GLUTAMIC-ACID
| Molecular Weight | 177.156 | nRot | 4 |
| Heavy Atom Molecular Weight | 166.068 | nRig | 2 |
| Exact Molecular Weight | 177.064 | nRing | 0 |
| Solubility: LogS | -1.291 | nHRing | 0 |
| Solubility: LogP | -3.231 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 22.4647 |
| nHD | 4 | BPOL | 12.2013 |
| QED | 0.42 |
| Synth | 3.43 |
| Natural Product Likeliness | 1.11 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.237 |
| HIA | 0.03 |
| CACO-2 | -6.247 |
| MDCK | 0.0113008 |
| BBB | 0.328 |
| PPB | 0.0953185 |
| VDSS | 0.319 |
| FU | 0.816228 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.037 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.045 |
| CYP2c9-inh | 0.026 |
| CYP2c9-sub | 0.152 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.117 |
| CYP3a4-inh | 0.021 |
| CYP3a4-sub | 0.007 |
| CL | 2.097 |
| T12 | 0.638 |
| hERG | 0.01 |
| Ames | 0.02 |
| ROA | 0.008 |
| SkinSen | 0.119 |
| Carcinogencity | 0.011 |
| EI | 0.151 |
| Respiratory | 0.041 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.844933 |